This topic contains a solution. Click here to go to the answer

Author Question: Watson and Hoffman's study on leadership emergence with regard to gender-biased perceptions would ... (Read 75 times)

Tirant22

  • Hero Member
  • *****
  • Posts: 532
Watson and Hoffman's study on leadership emergence with regard to gender-biased
  perceptions would suggest
 
  a. Influential women were rated the same as men in terms of leadership.
  b. Women are much more likeable than men.
  c. Emergence in leadership has little to do with gender bias.
  d. There continue to be barriers to women's emergence as leaders in some settings.
  e. Men are always more influential within groups and organizations.

Question 2

Follower development level in SLII is determined by level of
 
  a. Competence and commitment
  b. Social judgment and cognitive ability
  c. Sociability and determination
  d. Task and directive behaviors



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

micaelaswann

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

D

Answer to Question 2

A




Tirant22

  • Member
  • Posts: 532
Reply 2 on: Jul 8, 2018
Gracias!


fatboyy09

  • Member
  • Posts: 358
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

In 2006, a generic antinausea drug named ondansetron was approved. It is used to stop nausea and vomiting associated with surgery, chemotherapy, and radiation therapy.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library